Yung‐Hung Luo

机构：National Yang Ming Chiao Tung University, Taipei Veterans General Hospital, National Taiwan University Hospital · ORCID：0000-0002-4194-162X

发表论文 110 篇 · 总被引 2411 次 · h-index 18

代表论文

• Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B) (2025 · Journal of Clinical Oncology · 被引 19)
• Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities (2024 · Oncology Reports · 被引 10)
• First-line immune checkpoint inhibitors plus chemotherapy in Taiwanese patients with extensive-stage small-cell lung cancer (2025 · Journal of the Chinese Medical Association · 被引 9)
• Real-world therapeutic strategies and survival outcomes in advanced HER2-mutant non-small cell lung cancer (2025 · Journal of the Chinese Medical Association · 被引 7)
• Treatment patterns and survival outcomes in patients with small-cell lung cancer following failure of first-line platinum-based chemotherapy (2025 · Clinical & Translational Oncology · 被引 3)
• BBB-penetrant tyrosine kinase inhibitor plus intracranial radiotherapy vs BBB-penetrant TKI alone in Asians with EGFR-mutated lung adenocarcinoma and brain metastases (2025 · Journal of the Chinese Medical Association · 被引 2)